ESC 365 - Effects of sodium-glucose contrasporter-2 inhibitors and glucagon-like peptide-1 receptor agonists on arterial stiffness, coronary flow reserve and liver steatosis in diabetes

ESC Premium Access

Effects of sodium-glucose contrasporter-2 inhibitors and glucagon-like peptide-1 receptor agonists on arterial stiffness, coronary flow reserve and liver steatosis in diabetes

Session: Diabetes: a risk factor in heart disease

Topic: Metabolic Syndrome, Insulin, Insulin Resistance

Speaker: Doctor K. Katogiannis (Athens, GR)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Doctor Konstantinos Katogiannis

Attikon University Hospital, Athens (Greece)

1 presentation

0 follower

7 more presentations in this session

Diabetes Mellitus influence in Lipoprotein(a) gene expression and association to coronary artery disease

Speaker: Doctor D. Sa (Funchal, PT)

BMI shift and associated cardiometabolic risk factors in people with type 2 diabetes and obesity and/or overweight: a post hoc analysis from SURMOUNT-2

Speaker: Doctor N. Sattar (Glasgow, GB)

Social vulnerability and disparities in incidence of diagnosed diabetes in the united states, 2004 to 2019

Speaker: Doctor S. Ayanian (Rochester, US)

Plasma proteomics of all-cause and cause-specific mortality in individuals with and without type 2 diabetes: Results from two population-based KORA cohorts

Speaker: Miss H. Luo (Munich, DE)

Prevalence and incidence of heart failure in patients with type 2 diabetes mellitus. Results of the prospective DIABET-IC study

Speaker: Doctor R. Gonzalez-Manzanares (Cordoba, ES)

Access the full session

Diabetes: a risk factor in heart disease

Speakers: Doctor K. Katogiannis, Doctor D. Sa, Doctor N. Sattar, Doctor S. Ayanian, Miss H. Luo...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources